Temotero contains Temozolomide, an oral alkylating antineoplastic medicine used primarily in the treatment of glioblastoma and other malignant gliomas.

Temozolomide is converted under physiological conditions to an active alkylating compound that modifies DNA, particularly at specific guanine residues. This DNA damage can interfere with replication and cellular repair mechanisms, ultimately inhibiting the growth and survival of susceptible tumor cells.

Temozolomide is commonly used alongside radiotherapy and may subsequently be continued as maintenance therapy depending on the treatment protocol.

What are Temozolomide Capsules?

Temozolomide Capsules are an oral alkylating chemotherapy medicine. They are designed for systemic treatment of certain malignant brain tumors and other selected gliomas according to established oncology protocols.

Benefits / Uses

Temotero (Temozolomide Capsules) may be used in the treatment of:

• Newly diagnosed glioblastoma
• Anaplastic astrocytoma
• Recurrent or progressive malignant glioma
• Other selected malignant gliomas according to specialist oncology protocols

Treatment may involve Temozolomide alone or in combination with radiotherapy and other therapies, depending on the clinical setting.

Dosage Guidelines

Temozolomide dosing depends on the specific diagnosis, treatment phase, body surface area, blood counts, previous therapy, and the prescribed oncology protocol.

• Take exactly as prescribed by the treating oncologist.
• Capsules are generally swallowed whole with water and should not be opened or chewed.
• Administration may be scheduled once daily during specific treatment cycles.
• In newly diagnosed glioblastoma, Temozolomide is commonly used concurrently with radiotherapy followed by maintenance cycles, according to the established protocol.
• Complete blood counts should be monitored regularly.
• Liver and other relevant laboratory parameters may also be monitored.
• Dose interruption or adjustment may be required because of hematological or other significant toxicity.

Wholesale & Supply

Temotero (Temozolomide Capsules) may be supplied for pharmaceutical wholesale and institutional procurement, subject to applicable regulatory requirements and destination-country regulations.

Bulk procurement enquiries may include:

• Available capsule strengths
• Packaging configuration
• Certificate of Analysis (CoA)
• Batch information
• Manufacturing documentation
• Export and shipping documentation

Buying Online

Temozolomide is a prescription anticancer medicine and should be sourced through authorized pharmaceutical distributors, hospitals, pharmacies, or other licensed healthcare channels.

Reviews

Individual responses to Temozolomide vary according to tumor type, molecular characteristics, treatment regimen, disease status, and patient-specific factors. Treatment response and tolerability should be assessed by the treating oncology team.

Quality Assurance

Temozolomide products should undergo appropriate pharmaceutical quality-control testing according to applicable standards, including relevant testing for identity, potency, purity, and formulation-specific quality requirements.

Frequently Asked Questions

What is Temotero used for?

Temotero contains Temozolomide and is primarily used for glioblastoma and other selected malignant gliomas.

What type of medicine is Temozolomide?

Temozolomide is an oral alkylating antineoplastic agent used as chemotherapy for certain brain tumors.

How does Temozolomide work?

Temozolomide produces DNA alkylation that damages tumor-cell DNA and interferes with DNA replication and cellular survival.

How are Temozolomide Capsules taken?

Temozolomide Capsules are generally swallowed whole with water according to the prescribed treatment schedule. They should not be opened, crushed, or chewed.

Can Temozolomide be used with radiotherapy?

Yes. In newly diagnosed glioblastoma, Temozolomide is commonly administered concurrently with radiotherapy and subsequently as maintenance therapy according to the prescribed protocol.

What are the important side effects of Temozolomide?

Potential adverse effects include nausea, vomiting, fatigue, headache, constipation, and bone-marrow suppression, including reduced blood-cell counts. Serious infections and other complications may occur in some patients.

Does Temozolomide require blood-test monitoring?

Yes. Complete blood counts are important during treatment, and liver-function monitoring may also be performed according to the treatment protocol.

Who should prescribe Temotero?

Temotero should be prescribed and managed by a qualified oncologist or other healthcare professional experienced in the treatment of malignant brain tumors.

Conclusion

Temotero (Temozolomide Capsules) is an oral alkylating chemotherapy medicine with an important role in the treatment of glioblastoma and selected malignant gliomas. It works by causing DNA damage in susceptible tumor cells and is frequently incorporated into treatment protocols involving radiotherapy and maintenance therapy. Because Temozolomide can cause significant hematological and other adverse effects, specialist supervision and appropriate laboratory monitoring are essential.